Diagnostic and prognostic analysis indicated that DUXAP8, MEGEA1, MKRN3, and DGKI can be used to diagnosis HCC, while DUXAP8 and RNF2 can be used to predict the prognosis of HCC. Here, DUXAP8 is linked to hepatocellular carcinoma.